Skip to content

US · PG · HOUSEHOLD & PERSONAL PRODUCTS

The Procter & Gamble Company (PG) intrinsic value and stock valuation

$169.37as of 2026-11-21 · Mkt cap 348.95B

Data updated · price as of 2026-11-21

OvervaluedIC value is 20–50% below the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

The Procter & Gamble Company DCF and intrinsic value

InvestorsCraft values PG with the Chepakovich two-stage DCF model — currently rated overvalued. How the model works · Run your own DCF prefilled from PG’s statements →

The Procter & Gamble Company Graham Number

Graham Number: $57.93d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Consumer Defensive · Household & Personal Products Cincinnati, OH 45202 pginvestor.com

How the business is doing

Fiscal 2012–2026, USD

Revenue
$87B+2.7% 5y CAGRd
20122026
Net income
$16B+2.3% 5y CAGRd
20122026
Free cash flow
$15.9B+0.4% 5y CAGRd
20122026
Total equity
$54.5B+3.2% 5y CAGRd
20122026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2012–2026, USD
20262025202420232022
Revenue$87B$84.3B$84B$82B$80.2B
Operating income$19.7B$20.5B$18.5B$18.1B$17.8B
Net income$16B$16B$14.9B$14.7B$14.7B
EPSd$6.62M$6.51M$6.02M$5.9M$5.81M
Operating cash flow$20.3B$17.8B$19.8B$16.8B$16.7B
Capital expenditure-$-4.41B-$-3.77B-$-3.32B-$-3.06B-$-3.16B
Free cash flow$15.9B$14B$16.5B$13.8B$13.6B
Total assets$126.5B$125.2B$122.4B$120.8B$117.2B
Total debt$35B$35.5B$33.4B$35.4B$32.3B
Net debt$25.1B$25.9B$23.9B$27.2B$25.1B
Total equity$54.5B$52.3B$50.6B$47.1B$46.9B
Cash and short-term investments$9.94B$9.56B$9.48B$8.25B$7.21B
Income statement
20262025202420232022
Revenue$87B$84.3B$84B$82B$80.2B
Cost of revenue$43.4B$41.2B$40.8B$42.8B$42.2B
Gross profit$43.7B$43.1B$43.2B$39.2B$38B
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$23.9B$22.7B$23.3B$21.1B$20.2B
Other expenses$0.00$0.00$1.34B$0.00$0.00
Operating expenses$23.9B$22.7B$24.6B$21.1B$20.2B
Cost and expenses$67.3B$63.8B$65.5B$63.9B$62.4B
Interest income$430M$469M$473M$307M$51M
Interest expense$877M$907M$925M$756M$439M
Depreciation and amortization$0.00$2.85B$2.9B$2.71B$2.81B
Ebitda$21.3B$23.9B$22.6B$21.8B$21.2B
Operating income$19.7B$20.5B$18.5B$18.1B$17.8B
Total other income/expenses, net$629M-$-284M$216M$219M$182M
Income before tax$20.4B$20.2B$18.8B$18.4B$18B
Income tax expense$4.23B$4.1B$3.79B$3.62B$3.2B
Net income$16B$16B$14.9B$14.7B$14.7B
Weighted average shares outstanding$2.42B$2.45B$2.36B$2.37B$2.46B
Weighted average diluted shares outstanding$2.42B$2.45B$2.47B$2.48B$2.54B
Balance sheet
20262025202420232022
Cash and short-term investments$9.94B$9.56B$9.48B$8.25B$7.21B
Net receivables$6.06B$6.19B$6.12B$5.47B$5.14B
Inventory$8.17B$7.55B$7.02B$7.07B$6.92B
Total current assets$26.2B$25.4B$24.7B$22.6B$21.7B
Property, plant and equipment, net$25.4B$23.9B$22.2B$21.9B$21.2B
Goodwill and intangible assets$62.7B$63.6B$62.4B$64.4B$63.4B
Long-term investments$0.00$0.00$0.00$0.00$140M
Total non-current assets$100.3B$99.8B$97.7B$98.2B$95.6B
Total assets$126.5B$125.2B$122.4B$120.8B$117.2B
Accounts payable$16.3B$15.2B$15.4B$14.6B$14.9B
Short-term debt$11.5B$9.77B$7.43B$10.5B$8.85B
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$38.7B$36.1B$33.6B$35.8B$33.1B
Long-term debt$23.5B$25.7B$25.9B$25B$23.4B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$33.5B$36.9B$38.2B$38B$37.3B
Capital lease obligations$887M$956M$909M$817M$800M
Total liabilities$72.2B$72.9B$71.8B$73.8B$70.4B
Common stock$4.01B$4.01B$4.01B$4.01B$4.01B
Retained earnings$135.9B$130B$123.8B$118.2B$112.4B
Accumulated other comprehensive income (loss)-$-12.47B-$-12.14B-$-11.9B-$-12.22B-$-12.19B
Total equity$54.5B$52.3B$50.6B$47.1B$46.9B
Total investments$0.00$0.00$0.00$0.00$140M
Total debt$35B$35.5B$33.4B$35.4B$32.3B
Net debt$25.1B$25.9B$23.9B$27.2B$25.1B
Cash flow statement
20262025202420232022
Net income$16.1B$16.1B$14.9B$14.7B$14.8B
Depreciation and amortization$3.16B$2.85B$2.9B$2.71B$2.81B
Stock-based compensation$524M$476M$562M$545M$528M
Change in working capital$2M-$-2.47B-$-436M-$-1.22B-$-1.15B
Accounts receivable$84M$45M-$-766M-$-307M-$-694M
Inventory-$-641M-$-324M-$-70M-$-119M-$-1.25B
Accounts payable$919M-$-542M$1.81B$313M$1.43B
Net cash provided by operating activities$20.3B$17.8B$19.8B$16.8B$16.7B
Investments in property, plant and equipment-$-4.41B-$-3.77B-$-3.32B-$-3.06B-$-3.16B
Acquisitions, net-$-77M-$-11M-$-21M-$-765M-$-1.38B
Net cash used for investing activities-$-4.62B-$-3.82B-$-3.5B-$-3.5B-$-4.42B
Common stock issued$798M$1.71B$0.00$0.00$0.00
Common stock repurchased-$-5.03B-$-6.5B-$-5.01B-$-7.35B-$-10B
Dividends paid-$-10.23B-$-9.87B-$-9.31B-$-9B-$-8.77B
Net cash used for financing activities-$-15.2B-$-14.04B-$-14.86B-$-12.15B-$-14.88B
Net change in cash$412M$74M$1.24B$1.03B-$-3.07B
Cash at end of period$9.97B$9.56B$9.48B$8.25B$7.21B
Operating cash flow$20.3B$17.8B$19.8B$16.8B$16.7B
Capital expenditure-$-4.41B-$-3.77B-$-3.32B-$-3.06B-$-3.16B
Free cash flow$15.9B$14B$16.5B$13.8B$13.6B
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About The Procter & Gamble Company

        The Procter & Gamble Company, commonly referred to as P&G, is a global enterprise that supplies a broad spectrum of branded consumer products to markets worldwide. The company's operations are divided into five main business divisions: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers an assortment of hair care products, including conditioners, shampoos, styling aids, and treatments, under popular names like Head & Shoulders, Herbal Essences, Pantene, and Rejoice. It also features antiperspirants, deodorants, personal cleansing solutions, and skin care items from brands such as Olay, Old Spice, Safeguard, Secret, and SK-II. Within the Grooming division, P&G provides a range of shave care products and grooming appliances, prominently featuring brands like Braun, Gillette, and Venus. The Health Care unit encompasses oral hygiene essentials, including toothbrushes, toothpastes, and other dental care products sold under the Crest and Oral-B brand names. This segment further extends to gastrointestinal remedies, rapid diagnostics, respiratory care, vitamins/minerals/supplements, pain relief, and various other personal health care items from brands such as Metamucil, Neurobion, Pepto-Bismol, and Vicks. In the Fabric & Home Care category, consumers find fabric enhancers, laundry additives, and laundry detergents through labels like Ariel, Downy, Gain, and Tide. Additionally, this division offers air care products, dishwashing solutions, professional cleaning supplies (P&G Professional), and surface cleaners, exemplified by brands such as Cascade, Dawn, Fairy, Febreze, Mr. Clean, and Swiffer. Finally, the Baby, Feminine & Family Care segment provides infant care products, including baby wipes, taped diapers, and pants, under the Luvs and Pampers brands. It also supplies adult incontinence and feminine hygiene products from Always, Always Discreet, and Tampax, along with paper towels, tissues, and toilet paper marketed as Bounty, Charmin, and Puffs. P&G distributes its extensive product portfolio through a vast commercial network, including large retail chains, e-commerce platforms, grocery stores, membership clubs, pharmacies, department stores, various distributors, wholesalers, specialty beauty retailers, high-frequency stores, electronics outlets, and professional channels, as well as direct-to-consumer sales. The Procter & Gamble Company was established in 1837 and its corporate headquarters are located in Cincinnati, Ohio.

        CEO
        Shailesh G. Jejurikar
        Employees
        109K
        Beta
        0.38

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of The Procter & Gamble Company (PG)?

        The Procter & Gamble Company (PG) is currently overvalued based on the InvestorsCraft IC model — IC value is 20–50% below the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is PG undervalued?

        PG trades at a price of $169.37 (Nov 21, 2026): overvalued — IC value is 20–50% below the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.